A detailed history of Highland Capital Management Fund Advisors, L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, Highland Capital Management Fund Advisors, L.P. holds 166,377 shares of CTLT stock, worth $9.82 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
166,377
Holding current value
$9.82 Million
% of portfolio
1.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $9.34 Million - $10.1 Million
166,377 New
166,377 $10.1 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.